IVERIC bio ISEE

$ 39.95 0.0%

Quarterly report 2023-Q1
added 05-10-2023

IVERIC bio Balance Sheet 2011-2024 | ISEE

Annual Balance Sheet IVERIC bio

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-379 M	-260 M	-66.3 M	-125 M	-131 M	-167 M	-134 M	-222 M	-39.8 M	-211 M	6.74 M	-6.4 M
Long Term Debt	96.6 M	619 K	61 K	-	-	-	-	-	-	-	-	-
Long Term Debt Current	1.19 M	952 K	54 K	495 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	125 M	328 M	331 M	331 M	41.7 M	-	-
Total Current Liabilities	35.6 M	28.2 M	25.1 M	13 M	13.2 M	12.5 M	65.9 M	37.5 M	19.8 M	6.3 M	-	-
Total Liabilities	132 M	28.8 M	25.2 M	13 M	13.2 M	138 M	394 M	369 M	351 M	48 M	14.4 M	3.34 M
Deferred Revenue	-	-	-	-	-	-	6.65 M	6.67 M	3.21 M	-	-	-
Retained Earnings	-865 M	-680 M	-565 M	-481 M	-422 M	-485 M	-599 M	-406 M	-281 M	-183 M	-126 M	-105 M
Total Assets	667 M	389 M	217 M	130 M	137 M	176 M	300 M	429 M	498 M	218 M	4.88 M	7.73 M
Cash and Cash Equivalents	476 M	261 M	66.4 M	126 M	131 M	167 M	134 M	222 M	39.8 M	211 M	4.3 M	6.4 M
Book Value	535 M	361 M	192 M	117 M	124 M	38 M	-94.6 M	59.9 M	147 M	170 M	-9.53 M	4.39 M
Total Shareholders Equity	535 M	361 M	192 M	117 M	124 M	38 M	-94.6 M	59.9 M	129 M	170 M	-123 M	-102 M

All numbers in USD currency

Quarterly Balance Sheet IVERIC bio

	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	97 M	96.6 M	47.6 M	-	385 K	619 K	861 K	1.1 M	51 K	61 K	61 K	61 K	61 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	136 M	132 M	72.3 M	-	19.6 M	28.8 M	21.3 M	26.1 M	20.2 M	25.2 M	25.2 M	25.2 M	25.2 M	13 M	13 M	13 M	13 M	13.2 M	13.2 M	13.2 M	13.2 M	138 M	138 M	138 M	138 M	394 M	394 M	394 M	394 M	369 M	369 M	369 M	369 M	351 M	351 M	351 M	351 M	48 M	48 M	48 M	48 M	14.4 M	14.4 M	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6.65 M	6.65 M	6.65 M	6.65 M	6.65 M	6.65 M	6.67 M	6.67 M	6.67 M	6.67 M	3.21 M	3.21 M	3.21 M	3.21 M	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-937 M	-865 M	-806 M	-	-714 M	-680 M	-647 M	-622 M	-592 M	-565 M	-565 M	-565 M	-565 M	-481 M	-481 M	-481 M	-481 M	-422 M	-422 M	-422 M	-422 M	-485 M	-485 M	-485 M	-485 M	-599 M	-599 M	-599 M	-599 M	-406 M	-406 M	-406 M	-406 M	-300 M	-300 M	-300 M	-300 M	-183 M	-183 M	-	-	-	-	-	-	-	-	-	-
Total Assets	613 M	667 M	332 M	-	353 M	389 M	248 M	166 M	187 M	217 M	217 M	217 M	217 M	130 M	130 M	130 M	130 M	137 M	137 M	137 M	137 M	176 M	176 M	176 M	176 M	300 M	300 M	300 M	300 M	429 M	429 M	429 M	429 M	480 M	480 M	480 M	480 M	218 M	218 M	218 M	218 M	4.88 M	4.88 M	-	-	-	-	-	-
Cash and Cash Equivalents	468 M	476 M	153 M	-	192 M	261 M	180 M	50.4 M	29.3 M	66.4 M	66.4 M	66.4 M	66.4 M	126 M	126 M	126 M	126 M	131 M	131 M	131 M	131 M	167 M	167 M	167 M	167 M	134 M	134 M	134 M	134 M	222 M	222 M	222 M	222 M	39.8 M	39.8 M	39.8 M	39.8 M	211 M	211 M	211 M	211 M	4.3 M	4.3 M	-	-	6.4 M	-	-	-
Book Value	477 M	535 M	260 M	-	333 M	361 M	226 M	140 M	167 M	192 M	192 M	192 M	192 M	117 M	117 M	117 M	117 M	124 M	124 M	124 M	124 M	38 M	38 M	38 M	38 M	-94.6 M	-94.6 M	-94.6 M	-94.6 M	59.9 M	59.9 M	59.9 M	59.9 M	129 M	129 M	129 M	129 M	170 M	170 M	170 M	170 M	-9.53 M	-9.53 M	-	-	-	-	-	-
Total Shareholders Equity	477 M	535 M	260 M	293 M	333 M	361 M	226 M	140 M	167 M	192 M	192 M	192 M	192 M	117 M	117 M	117 M	117 M	124 M	124 M	124 M	124 M	38 M	38 M	38 M	38 M	-94.6 M	-94.6 M	-94.6 M	-94.6 M	59.9 M	59.9 M	59.9 M	59.9 M	129 M	129 M	129 M	129 M	170 M	170 M	170 M	170 M	-123 M	-123 M	-	-	-102 M	-	-	-

All numbers in USD currency